UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Amyloid β-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease

Journal of peptide science, 2004-05, Vol.10 (5), p.229-248

2004

Volltextzugriff (PDF)

A correlation of endocrine and anticancer effects of some antagonists of GHRH

Peptides (New York, N.Y. : 1980), 2010-10, Vol.31 (10), p.1839-1846

2010

Volltextzugriff (PDF)

Endomorphin-2, an endogenous tetrapeptide, protects against Aβ1-42 in vitro and in vivo

The FASEB journal, 2006-06, Vol.20 (8), p.1191-1193

2006

Volltextzugriff (PDF)

β-Amyloid-derived pentapeptide RIIGL a inhibits Aβ 1–42 aggregation and toxicity

Biochemical and biophysical research communications, 2004-11, Vol.324 (1), p.64-69

2004

Volltextzugriff (PDF)

Short analogs and mimetics of human urocortin 3 display antidepressant effects in vivo

Peptides (New York, N.Y. : 1980), 2014-12, Vol.62, p.59-66

2014

Volltextzugriff (PDF)

Antiamnesic properties of analogs and mimetics of the tripeptide human urocortin 3

Amino acids, 2016-09, Vol.48 (9), p.2261-2266

2016

Volltextzugriff (PDF)

Controlled in situ preparation of Aβ(1–42) oligomers from the isopeptide “iso-Aβ(1–42)”, physicochemical and biological characterization

Peptides (New York, N.Y. : 1980), 2010-02, Vol.31 (2), p.248-256

2010

Volltextzugriff (PDF)

Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases

Proceedings of the National Academy of Sciences - PNAS, 2012-01, Vol.109 (5), p.1655-1660

2012

Volltextzugriff (PDF)

Preclinical efficacy of growth hormone-releasing hormone antagonists for androgen-dependent and castration-resistant human prostate cancer

Proceedings of the National Academy of Sciences - PNAS, 2014-01, Vol.111 (3), p.1084-1089

2014

Volltextzugriff (PDF)

Pentapeptide Amides Interfere with the Aggregation of β-Amyloid Peptide of Alzheimer's Disease

Biochemical and biophysical research communications, 2002-04, Vol.292 (4), p.931-936

2002

Volltextzugriff (PDF)

Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia

Proceedings of the National Academy of Sciences - PNAS, 2011-03, Vol.108 (9), p.3755-3760

2011

Volltextzugriff (PDF)

In vitro model of neurotoxicity of Aβ 1–42 and neuroprotection by a pentapeptide: irreversible events during the first hour

Neurobiology of disease, 2004-12, Vol.17 (3), p.507-515

2004

Volltextzugriff (PDF)

Agonistic analogs of growth hormone releasing hormone (GHRH) promote wound healing by stimulating the proliferation and survival of human dermal fibroblasts through ERK and AKT pathways

Oncotarget, 2016-08, Vol.7 (33), p.52661-52672

2016

Volltextzugriff (PDF)

Beta-amyloid-derived pentapeptide RIIGLa inhibits Abeta(1-42) aggregation and toxicity

Biochemical and biophysical research communications, 2004-11, Vol.324 (1), p.64

2004

Volltextzugriff (PDF)

β-Amyloid-derived pentapeptide RIIGLa inhibits Aβ1–42 aggregation and toxicity

Biochemical and biophysical research communications, 2004-11, Vol.324 (1), p.64-69

2004

Volltextzugriff (PDF)

Differences between normal and alpha-synuclein overexpressing SH-SY5Y neuroblastoma cells after Abeta(1-42) and NAC treatment

Brain research bulletin, 2008-03, Vol.75 (5), p.648

2008

Volltextzugriff (PDF)

Endocrine and antineoplastic actions of growth hormone-releasing hormone antagonists

Current medicinal chemistry, 2008-02, Vol.15 (4), p.314-321

2008

Volltextzugriff (PDF)

Endomorphin-2, an endogenous tetrapeptide, protects against Abeta1-42 in vitro and in vivo

The FASEB journal, 2006-06, Vol.20 (8), p.1191

2006

Volltextzugriff (PDF)

The Expression of the Pituitary Growth Hormone-Releasing Hormone Receptor and Its Splice Variants in Normal and Neoplastic Human Tissues

Proceedings of the National Academy of Sciences - PNAS, 2005-11, Vol.102 (48), p.17424-17429

2005

Volltextzugriff (PDF)

Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonists

Proceedings of the National Academy of Sciences - PNAS, 2014-01, Vol.111 (2), p.781-786

2014

Volltextzugriff (PDF)

Aggregation of Abeta(1-42) in the presence of short peptides: conformational studies

Journal of peptide science, 2008-06, Vol.14 (6), p.731-741

2008

Volltextzugriff (PDF)

Synthesis and Biological Evaluation of Antagonists of Growth Hormone-Releasing Hormone with High and Protracted in vivo Activities

Proceedings of the National Academy of Sciences - PNAS, 1999-01, Vol.96 (2), p.692-697

1999

Volltextzugriff (PDF)

Synthesis of Abeta[1-42] and its derivatives with improved efficiency

Journal of peptide science, 2007-02, Vol.13 (2), p.94

2007

Volltextzugriff (PDF)

Synthesis of Aβ[1-42] and its derivatives with improved efficiency

Journal of peptide science, 2007-02, Vol.13 (2), p.94-99

2007

Volltextzugriff (PDF)

GHRH antagonist causes DNA damage leading to p21 mediated cell cycle arrest and apoptosis in human colon cancer cells

Cell cycle (Georgetown, Tex.), 2009-10, Vol.8 (19), p.3149-3156

2009

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(95)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(68)
Life Sciences & Biomedicine
(55)
Humans
(52)
Animals
(49)
Growth Hormone-Releasing Hormone - Antagonists & Inhibitors
(37)
Male
(30)
Cell Line, Tumor
(28)
Tumors
(26)
Medical Sciences
(25)
Biological And Medical Sciences
(24)
Mice
(22)
Rats
(22)
Sermorelin - Analogs & Derivatives
(22)
Sermorelin - Pharmacology
(21)
Biochemistry & Molecular Biology
(20)
Oncology
(19)
Mice, Nude
(17)
Cancer
(14)
Endocrinology & Metabolism
(14)
Female
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Amyloid β-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease

A correlation of endocrine and anticancer effects of some antagonists of GHRH

Endomorphin-2, an endogenous tetrapeptide, protects against Aβ1-42 in vitro and in vivo

β-Amyloid-derived pentapeptide RIIGL a inhibits Aβ 1–42 aggregation and toxicity

Short analogs and mimetics of human urocortin 3 display antidepressant effects in vivo

Antiamnesic properties of analogs and mimetics of the tripeptide human urocortin 3

Controlled in situ preparation of Aβ(1–42) oligomers from the isopeptide “iso-Aβ(1–42)”, physicochemical and biological characterization

Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases

Preclinical efficacy of growth hormone-releasing hormone antagonists for androgen-dependent and castration-resistant human prostate cancer

Pentapeptide Amides Interfere with the Aggregation of β-Amyloid Peptide of Alzheimer's Disease

Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia

In vitro model of neurotoxicity of Aβ 1–42 and neuroprotection by a pentapeptide: irreversible events during the first hour

Agonistic analogs of growth hormone releasing hormone (GHRH) promote wound healing by stimulating the proliferation and survival of human dermal fibroblasts through ERK and AKT pathways

Beta-amyloid-derived pentapeptide RIIGLa inhibits Abeta(1-42) aggregation and toxicity

β-Amyloid-derived pentapeptide RIIGLa inhibits Aβ1–42 aggregation and toxicity

Differences between normal and alpha-synuclein overexpressing SH-SY5Y neuroblastoma cells after Abeta(1-42) and NAC treatment

Endocrine and antineoplastic actions of growth hormone-releasing hormone antagonists

Endomorphin-2, an endogenous tetrapeptide, protects against Abeta1-42 in vitro and in vivo

The Expression of the Pituitary Growth Hormone-Releasing Hormone Receptor and Its Splice Variants in Normal and Neoplastic Human Tissues

Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonists

Aggregation of Abeta(1-42) in the presence of short peptides: conformational studies

Synthesis and Biological Evaluation of Antagonists of Growth Hormone-Releasing Hormone with High and Protracted in vivo Activities

Synthesis of Abeta[1-42] and its derivatives with improved efficiency

Synthesis of Aβ[1-42] and its derivatives with improved efficiency

GHRH antagonist causes DNA damage leading to p21 mediated cell cycle arrest and apoptosis in human colon cancer cells

Suchergebnisse filtern